Applications of VirScan to broad serological profiling of bat reservoirs for emerging zoonoses

A human-virome peptide library, applied unmodified to bat serum, surfaces 57 viral genera of zoonotic concern from a single PhIP-Seq run.

Cornelius Ruhs E, Chia WN, Foo R, Peel AJ, Li Y, Larman HB, Irving AT, Wang L, Brook CE.

Frontiers in Public Health · September 22, 2023 · DOI: 10.3389/fpubh.2023.1212018

How to cite

AMA

Cornelius Ruhs E, Chia WN, Foo R, et al. Applications of VirScan to broad serological profiling of bat reservoirs for emerging zoonoses. Front Public Health. 2023;11:1212018. doi:10.3389/fpubh.2023.1212018

APA

Cornelius Ruhs, E., Chia, W. N., Foo, R., Peel, A. J., Li, Y., Larman, H. B., Irving, A. T., Wang, L., & Brook, C. E. (2023). Applications of VirScan to broad serological profiling of bat reservoirs for emerging zoonoses. Frontiers in Public Health, 11, 1212018. https://doi.org/10.3389/fpubh.2023.1212018

BibTeX

@article{corneliusruhs2023virscanbats,
  author  = {Cornelius Ruhs, Emily and Chia, Wan Ni and Foo, Randy and Peel, Alison J. and Li, Yimei and Larman, H. Benjamin and Irving, Aaron T. and Wang, Linfa and Brook, Cara E.},
  title   = {Applications of {VirScan} to broad serological profiling of bat reservoirs for emerging zoonoses},
  journal = {Frontiers in Public Health},
  volume  = {11},
  pages   = {1212018},
  year    = {2023},
  doi     = {10.3389/fpubh.2023.1212018}
}

The first published application of Phage ImmunoPrecipitation Sequencing (PhIP-Seq) to bat serum, this study repurposes the human-virome VirScan library — without species-specific reagent redesign — to recover broad antibody-exposure histories in two bat species. The result establishes virome-scale antibody reactome profiling as a hypothesis-free complement to PCR-based pathogen surveillance in zoonotic reservoirs.

In this publication:

Bats host an unusually large number of viruses that can spill over into humans and cause severe disease — Hendra and Nipah henipaviruses, Marburg filovirus, rabies lyssavirus, and many coronaviruses among them — yet bats themselves rarely show clinical illness from these infections. Surveying which viruses any given bat population has been exposed to is hard: viral shedding is transient, traditional ELISA and virus-neutralization assays test only one antigen at a time, and field capture is logistically difficult.

This paper introduces a different approach. The authors took serum from two bat species — semi-captive Australian black flying foxes (Pteropus alecto) and captive Singaporean cave nectar bats (Eonycteris spelaea) — and ran each sample through the VirScan PhIP-Seq library, a bacteriophage-displayed collection of 56-mer peptides covering more than 200 viral species and 1,000 strains across the entire known human virome. By measuring which peptides each bat’s antibodies bound, they recovered a per-bat fingerprint of past viral exposures, then deconvoluted those fingerprints with the AVARDA algorithm to assign exposures to specific viral genera.

Despite the library being human-designed, the assay surfaced biologically plausible exposure histories: 57 viral genera in P. alecto and 9 in E. spelaea, including expected zoonotic groups. Pre-pandemic biosurveillance gains a virome-scale lever: a single PhIP-Seq run against the full human virome turns banked serum aliquots into hypothesis-free spillover-risk readouts, generalizable beyond Homo sapiens to mammalian reservoirs across One Health programs.

← Back to all resources

Related resources

White Paper

Unbiased analysis of antibody responses to all human viruses using Infinity Bio's VirSIGHT library

A peer-reviewed methodology white paper for VirSIGHT, Infinity Bio's unbiased antibody reactome assay covering 500+ huma…

Read more
Brochure

VirSIGHT InSIGHTs

VirSIGHT at a glance: antibody reactome profiling across the known human virome (500+ species).

Read more
Brochure

Antibody Reactomics: The Responsive Layer of Immune Memory

Where the antibody reactome fits in the multi-omic stack, how MIPSA deciphers it, and what the HuSIGHT, VirSIGHT, and En…

Read more
Publication

Viral Immunity in Immunoglobulin Products, Global Immunity Debt and Autoimmunity

Lindahl et al., 2026: viral immunity in IgG products and global immunity debt.

Read more
Publication

Comprehensive profiling of pre-infection antibodies identifies HIV targets associated with viremic control and viral load

Frontiers Immunol 2023: pre-infection antibody reactome predicts post-infection HIV viral control.

Read more
Publication

Comprehensive profiling of antibody responses to the human anellome using programmable phage display

Antibody reactome profiling of the human anellome: small DNA viruses persisting in healthy hosts.

Read more
Publication

Greater Breadth of Vaccine-Induced Immunity in Females than Males Is Mediated by Increased Antibody Diversity in Germinal Center B Cells

Females develop broader vaccine-induced antibody repertoires, driven by germinal-center B-cell diversity.

Read more
Publication

Phage display of environmental protein toxins and virulence factors reveals the prevalence, persistence, and genetics of antibody responses

Antibody responses to environmental toxins and microbial virulence factors at population scale.

Read more
Publication

Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis

Bjornevik et al., Science 2022: 10M serial serum samples link EBV to multiple sclerosis.

Read more
Publication

Analysis of antibody binding specificities in twin and SNP-genotyped cohorts reveals that antiviral antibody epitope selection is a heritable trait

Antibody epitope selection is partially heritable, shown across twin and SNP-genotyped cohorts.

Read more
Publication

Deconvoluting virome-wide antibody epitope reactivity profiles

Bioinformatic deconvolution of cross-reactive signals in virome-wide antibody reactome data.

Read more
Publication

SARS-CoV-2 antibody signatures robustly predict diverse antiviral functions relevant for convalescent plasma therapy

SARS-CoV-2 antibody signatures predict convalescent plasma antiviral function.

Read more